SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001689813-22-000041
Filing Date
2022-05-10
Accepted
2022-05-10 17:27:15
Documents
87
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bhvn-20220331.htm   iXBRL 10-Q 1700376
2 EX-2.1 a2022q1bhvn10-qexhibit21.htm EX-2.1 974431
3 EX-31.1 a2022q1bhvn10-qexhibit311.htm EX-31.1 10524
4 EX-31.2 a2022q1bhvn10-qexhibit312.htm EX-31.2 10738
5 EX-32.1 a2022q1bhvn10-qexhibit321.htm EX-32.1 7600
11 GRAPHIC bhvn-20220331_g1.jpg GRAPHIC 23128
12 GRAPHIC bhvn-20220331_g2.jpg GRAPHIC 85295
  Complete submission text file 0001689813-22-000041.txt   10665211

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20220331.xsd EX-101.SCH 76746
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhvn-20220331_cal.xml EX-101.CAL 83102
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhvn-20220331_def.xml EX-101.DEF 395387
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20220331_lab.xml EX-101.LAB 818819
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20220331_pre.xml EX-101.PRE 561410
81 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20220331_htm.xml XML 1626355
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38080 | Film No.: 22911185
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences